These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 16094089)
21. Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: preliminary results of a prospective phase II study. Maluta S; Dall'Oglio S; Romano M; Marciai N; Pioli F; Giri MG; Benecchi PL; Comunale L; Porcaro AB Int J Hyperthermia; 2007 Aug; 23(5):451-6. PubMed ID: 17701536 [TBL] [Abstract][Full Text] [Related]
22. Salvage surgery for locally recurrent prostate cancer after radiation therapy: tricks of the trade. Leibovici D; Spiess PE; Heller L; Rodriguez-Bigas M; Chang G; Pisters LL Urol Oncol; 2008; 26(1):9-16. PubMed ID: 18190824 [TBL] [Abstract][Full Text] [Related]
23. When prostate brachytherapy fails: a case report and discussion. Kadoch C; D'Amico AV; Matthews RH Oncologist; 2005; 10(10):799-805. PubMed ID: 16314290 [TBL] [Abstract][Full Text] [Related]
24. The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgery. Pucar D; Sella T; Schöder H Curr Opin Urol; 2008 Jan; 18(1):87-97. PubMed ID: 18090496 [TBL] [Abstract][Full Text] [Related]
25. Radiotherapy combined with hormonal therapy (RT-HT) in prostate cancer patients with low, intermediate, and high risk of biochemical recurrence: perspective and therapeutic gain analysis. Milecki P; Kwias Z; Martenka DJ Neoplasma; 2007; 54(1):7-15. PubMed ID: 17203887 [TBL] [Abstract][Full Text] [Related]
26. The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies. Huang WC; Kuroiwa K; Serio AM; Bianco FJ; Fine SW; Shayegan B; Scardino PT; Eastham JA J Urol; 2007 Apr; 177(4):1324-9; quiz 1591. PubMed ID: 17382724 [TBL] [Abstract][Full Text] [Related]
27. Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy. Cheung R; Kamat AM; de Crevoisier R; Allen PK; Lee AK; Tucker SL; Pisters L; Babaian RJ; Kuban D Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):134-40. PubMed ID: 16111581 [TBL] [Abstract][Full Text] [Related]
28. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients. Ismail M; Ahmed S; Kastner C; Davies J BJU Int; 2007 Oct; 100(4):760-4. PubMed ID: 17662081 [TBL] [Abstract][Full Text] [Related]
29. Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy. Wong GW; Palazzi-Churas KL; Jarrard DF; Paolone DR; Graf AK; Hedican SP; Wegenke JD; Ritter MA Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):449-55. PubMed ID: 17869014 [TBL] [Abstract][Full Text] [Related]
31. Salvage options for biochemical recurrence after primary therapy for prostate cancer. Bong GW; Keane TE Can J Urol; 2007 Dec; 14 Suppl 1():2-9. PubMed ID: 18163938 [TBL] [Abstract][Full Text] [Related]
32. Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy. Stephenson AJ; Eastham JA J Clin Oncol; 2005 Nov; 23(32):8198-203. PubMed ID: 16278473 [TBL] [Abstract][Full Text] [Related]
33. E-cadherin protein expression predicts prostate cancer salvage radiotherapy outcomes. Ray ME; Mehra R; Sandler HM; Daignault S; Shah RB J Urol; 2006 Oct; 176(4 Pt 1):1409-14; discussion 1414. PubMed ID: 16952645 [TBL] [Abstract][Full Text] [Related]
34. Changing the patterns of failure for high-risk prostate cancer patients by optimizing local control. Stock RG; Ho A; Cesaretti JA; Stone NN Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):389-94. PubMed ID: 16965991 [TBL] [Abstract][Full Text] [Related]
35. Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option. Allen GW; Howard AR; Jarrard DF; Ritter MA Cancer; 2007 Oct; 110(7):1405-16. PubMed ID: 17685384 [TBL] [Abstract][Full Text] [Related]
36. Treatment failure after primary and salvage therapy for prostate cancer. Pisters LL Cancer; 2008 Jan; 112(2):225-7. PubMed ID: 18050293 [No Abstract] [Full Text] [Related]
37. Perineal salvage prostatectomy for radiation resistant prostate cancer. van der Poel HG; Beetsma DB; van Boven H; Horenblas S Eur Urol; 2007 Jun; 51(6):1565-71; discussion 1572. PubMed ID: 16949728 [TBL] [Abstract][Full Text] [Related]
38. [Salvage radiotherapy for pT3 prostate cancer with PSA failure after radical prostatectomy]. Wakita T; Hayashi N; Fuwa N Hinyokika Kiyo; 2005 Sep; 51(9):575-80. PubMed ID: 16229369 [TBL] [Abstract][Full Text] [Related]
39. Radiation rescue for biochemical failure after surgery for prostate cancer: predictive parameters and an assessment of contemporary predictive models. Symon Z; Kundel Y; Sadetzki S; Oberman B; Ramon J; Laufer M; Catane R; Pfeffer MR Am J Clin Oncol; 2006 Oct; 29(5):446-50. PubMed ID: 17023777 [TBL] [Abstract][Full Text] [Related]
40. Salvage cryosurgical ablation of the prostate for local recurrence after radiation therapy: improved outcomes utilizing a capromab pendetide scan and biopsy algorithm. Clarke HS; Eskridge MR; El-Zawahry AM; Keane TE Can J Urol; 2007 Dec; 14 Suppl 1():24-7. PubMed ID: 18163941 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]